Arkolith/Insider Trading/CRBU/Form 4

Fischesser Ryan

VP of Finance and ControllerCaribou Biosciences, Inc. (CRBU) · full profile →Form 4 · filed Oct 7, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$108K
Net Open-Market Flow
-$108K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 6, 2022Option exercise(M)3K$2.69$8K113K
Oct 6, 2022Option exercise(M)3K$4.11$12K116K
Oct 6, 2022Sell(S)10K$10.80$108K110K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 6, 2022Option exercise(M)3K—$015K
Oct 6, 2022Option exercise(M)3K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001619856-22-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML